-
Corteva advances separation; EIDP noteholders consent to indenture amendments
Vylor received requisite consents for EIDP Notes (2.300% 2030, 5.125% 2032, 4.800% 2033) to amend indenture.
-
Corteva extends EIDP debt exchange offers to Sep 29; early tenders 86-94%
Early tender results: 2.300% notes due 2030 tendered $431.6M (86.33%); 5.125% notes due 2032 $468.4M (93.69%); 4.800% notes due 2033 $524.9M (87.48%).
-
Corteva subsidiary Vylor files amended Form 10 for seed business spin-off
Vylor, Inc., a Corteva subsidiary, filed first amendment to Form 10 on Aug 14, 2026.
-
Corteva's Vylor commences exchange offers for EIDP notes; targets debt/EBITDA 0.8-1.1x post-separation
Vylor expects debt/EBITDA leverage ratio of 0.8x-1.1x at Dec 31, 2026, targeting not to exceed 2.5x.
-
Corteva raises FY2026 guidance after strong 1H; Q2 operating EPS $2.30
Q2 GAAP EPS $1.81 vs $2.02 YoY; operating EPS $2.30, up 5% YoY.
-
Corteva announces post-spin-off boards for Corteva and Vylor; Q4 2026 separation on track
Four directors (Grimes, Lutz, Magro, Preete) resign from Corteva board to join Vylor board upon spin-off.
-
Corteva revises restructuring charges to $750M-$815M, adds Spain plant closure
Pre-tax charges now $750M-$815M, up $100M-$115M from prior estimate.
-
Corteva Delivers Strong Q1 2026: EPS $1.07 GAAP, $1.50 Operating; Reaffirms FY Outlook
Net sales $4.905B (+11% YoY); organic sales +7%. GAAP net income $725M ($1.07 EPS).
-
Corteva stockholders elect all 12 director nominees and approve say-on-pay at 2026 annual meeting
All 12 director nominees elected with strong majority support; broker non-votes 51.6M.
-
Corteva names Luke Kissam CEO of New Corteva; reveals SpinCo leadership for planned separation
Luke Kissam, former Albemarle CEO, to lead New Corteva (crop protection) at Q4 2026 spin-off; joins June 1 as crop protection BU CEO.
-
Corteva FY2025 sales $17.4B (+3%), EBITDA $3.85B; guides 2026 EBITDA $4.0-4.2B; settles Bayer
Full-year GAAP EPS from cont ops $1.75, up 43% YoY; Operating EPS $3.34, up 30%.
-
Corteva raises FY2025 guidance; Q3 op EBITDA $49M; plans spin-off in H2 2026
Q3 net sales $2.62B, +13% YoY; GAAP loss $308M (loss $0.46) vs loss $519M prior year.
-
Corteva to split into two public companies via tax-free spin-off by H2 2026
Board unanimously approved plan to separate into two independent public companies via tax-free spin-off expected in H2 2026.
-
Corteva appoints Jennifer Johnson Chief Legal Officer; Cornel Fuerer to retire in 2026
Jennifer Johnson becomes SVP, Chief Legal Officer effective Sept 15, 2025, succeeding Cornel Fuerer.
-
Corteva Q2 GAAP EPS $2.02, op EPS $2.20; raises FY2025 guidance
Q2 GAAP EPS $2.02 (up 34% YoY); operating EPS $2.20 (up 20%).
-
Corteva Q1 2025: EPS $0.97 GAAP, $1.13 operating; reaffirms FY guidance
GAAP EPS $0.97 from cont. ops (+83% YoY); operating EPS $1.13 (+27% YoY).
-
Corteva stockholders elect all 12 director nominees, approve say-on-pay, ratify PwC
All 12 director nominees elected; average ~98.2% votes for across candidates (excluding broker non-votes).
-
Corteva director Rebecca Liebert resigns, effective Feb 28, 2025
Rebecca Liebert, Ph.D. informed board on Feb 13, 2025 of resignation to pursue other opportunities.
-
Corteva: Q4 Op EPS $0.32 vs -$0.08 GAAP; Seed & Crop Protection volumes up; FY2025 guidance $2.70-$2.95 Op EPS
GAAP diluted EPS from continuing ops -$0.08 in Q4 vs -$0.33 a year ago; Operating EPS $0.32, up 113% YoY.
-
Corteva reports Q3 loss, updates FY guidance, announces restructuring cost increase
Q3 2024 net sales $2.33B (-10% YoY); GAAP loss from cont. ops $519M; GAAP EPS -$0.76.
-
Corteva names Judd O'Connor EVP Seed Business Unit as Tim Glenn retires Dec 1, 2024
Tim Glenn will retire effective December 1, 2024, and serve as strategic advisor through Q1 2025.
-
Corteva Q2 GAAP EPS $1.51, up 23% YoY; cuts FY guidance; names new CFO
Seed EBITDA +16% to $1.70B on 5% price lift; Crop Protection EBITDA -20% to $255M on pricing pressure.
-
Corteva stockholders approve officer exculpation amendment at annual meeting
All 13 director nominees elected with >94% support from votes cast, excluding broker non-votes.
-
Corteva Q1 net sales down 8% to $4.49B, EPS $0.53; reaffirms FY guidance
GAAP EPS from continuing ops $0.53 vs $0.84 prior year; operating EPS (non-GAAP) $0.89 vs $1.16.
-
Corteva reports FY2023 operating EBITDA up 5% to $3.38B; provides 2024 guidance with mid-point growth
Q4 net sales $3.71B (-3% YoY); GAAP loss from cont. ops $231M (EPS -$0.33).
-
Corteva Q3 net loss $315M; affirms FY guidance; announces $410-460M restructuring
Q3 net loss from continuing ops $315M, diluted EPS -$0.45; organic sales down 13% vs prior year.
-
Corteva lowers FY2023 guidance on Brazil headwinds; Q3 GAAP loss $0.45/sh
Q3 preliminary net sales ~$2.6B; GAAP loss from ops ~$315M (EPS $0.45).
-
Corteva Q2 GAAP EPS $1.23, cuts FY guidance; Seed EBITDA +18%, Crop Protection -37%
Q2 net sales $6.05B (-3% YoY); GAAP EPS $1.23 (-10%); Operating EPS $1.60 (-2%).
-
Corteva subsidiary EIDP issues $1.2B in senior notes at 4.500% and 4.800%
EIDP, Inc. issued $600M 4.500% Senior Notes due 2026 and $600M 4.800% Senior Notes due 2033.
-
Corteva Q1 organic sales up 10% to $5.06B; raises FY2023 guidance on strong price execution
GAAP EPS $0.84 vs $0.79 YoY; Operating EPS $1.16 vs $0.97, up 20% on price and productivity.
-
Corteva shareholders elect 13 directors, approve executive compensation, ratify PwC as auditor
All 13 director nominees elected; highest votes for Charles V. Magro (560.6M for), lowest for Gregory R. Page (514.7M for).
-
Corteva reports FY2022 operating EPS $2.67, net sales $17.46B; guides FY2023 operating EPS $2.70-$2.90
Q4 GAAP loss from continuing ops $41M, EPS -$0.06; operating EPS $0.16 (+100% YoY).
-
Corteva amends bylaws to align with universal proxy rules and Delaware law
Board approved Second Amended and Restated Bylaws effective December 15, 2022.
-
Corteva reports Q3 GAAP loss $322M; raises full-year EBITDA mid-point; to acquire Symborg
Q3 net sales $2.78B (+17% YoY); GAAP EPS $(0.45); operating EBITDA $96M vs ($51M) prior year.
-
Corteva Q2 sales $6.25B (+11% YoY), raises full-year EPS guidance to $2.45-$2.60
Q2 GAAP EPS $1.37 (flat YoY); Operating EPS $1.64 (+17%) on strong price execution.
-
Corteva shareholders elect all 13 director nominees, approve say-on-pay and auditor ratification
All 13 director nominees elected with strong support; each received >500M votes for.
-
Corteva Q1 2022 net sales up 10% to $4.6B; Operating EPS $0.97 beats year-ago $0.79
GAAP EPS $0.79 vs $0.81; Operating EPS $0.97, +23% YoY, on strong price execution and volume.
-
Corteva EVP Rajan Gajaria to retire Feb 18; Indianapolis named global HQ
Rajan Gajaria, Executive Vice President of Business Platforms, retiring effective February 18, 2022.
-
Corteva Q4 net sales +8% to $3.48B; FY21 EPS $2.44, guides FY22 EPS $2.30-$2.50
Q4 GAAP EPS from cont. ops $0.21 (+62% YoY); operating EPS $0.08 (+100% YoY).
-
Corteva Q3 net sales up 27% to $2.4B, raises full-year guidance, appoints new CEO Chuck Magro
Q3 GAAP EPS $0.05 (vs -$0.52 YoY); Operating EPS (non-GAAP) loss of $0.14, 64% improvement.
-
Corteva appoints former Nutrien CEO Chuck Magro as new CEO, effective Nov 1, 2021
Chuck Magro succeeds James C. Collins Jr., who is retiring; Magro joins board effective Nov 1.
-
Corteva raises full-year guidance after Q2 beat; EPS $1.37 GAAP, $1.40 operating
Q2 GAAP EPS $1.37, operating EPS $1.40; net sales $5.6B, +8% YoY.